AbbVie Wants To Be Hunter, Not Hunted Post-Abbott Split – Forbes
AbbVie Wants To Be Hunter, Not Hunted Post-Abbott Split
Forbes There are 10 drugs in the final so-called Phase III stage of drug development including a potentially promising next-generation hepatitis C drug; the intestinal gel Duopa for the treatment of advanced Parkinson’s disease; daclizumab for multiple … Which Abbott Is the One to Own Post-Split?Investorplace.com |